Streetbeat News

Partnerships

LIQT

LiqTech International, Inc. (NASDAQ:LIQT) has entered into a distribution agreement with Razorback Direct Oilfield Solutions and Services LLC to commercialize LiqTech's produced water treatment solution in five U.S. states. This solution, leveraging LiqTech's ceramic silicon carbide filtration technologies, aims at tertiary water treatment for re-injection, reuse, and lithium harvest. The partnership aims to expand LiqTech's presence in North America, focusing on sustainability, financial success, and regulatory compliance in the oil and gas industry.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 2:01 pm

GS

NUKK

Nukkleus Inc. (NASDAQ:NUKK) shares fell in premarket trading after a significant rise the previous day. The drop follows the announcement of a term sheet for acquiring Mercury Global, a cross-border payments firm. Additionally, Goldman Sachs Group, Inc. (NYSE:GS) holds a 7.2% passive stake in Nukkleus. Nukkleus also announced an MOU to increase its stake in Jacobi Asset Management and a payments partnership in Africa, potentially raising its ownership in Jacobi to about 20%.

Portfolio Pulse from Nabaparna Bhattacharya

February 14, 2024 | 2:00 pm

GE

RYCEY

TAWNF

Thai Airways International Pcl has chosen General Electric Co. over Rolls-Royce Holdings Plc for its next-generation widebody engines in a deal involving 45 Boeing Co. aircraft. This decision, influenced by previous criticisms of Rolls-Royce's pricing, marks a significant shift for Thai Airways and represents a notable loss for Rolls-Royce, which has been aiming to improve profitability. The engines will power Boeing aircraft to be added to Thai Airways' fleet from 2027 to 2033, a move that does not impact the airline's debt rehabilitation plans. This order is crucial for GE, especially ahead of its GE Aerospace and GE Vernova Spin-Off, and provides a boost to Boeing amidst its recent challenges.

Portfolio Pulse from Benzinga Neuro

February 14, 2024 | 1:49 pm

TCBP

TC BioPharm (Holdings) PLC (NASDAQ:TCBP), a clinical stage biotechnology company, announced significant operational achievements including FDA clearance for a Phase 1B study in AML, a new collaboration with Queen Mary University of London, and cost-savings of approximately $11.6M. The company successfully dosed the final patient in the ACHIEVE Study safety cohort and looks forward to interim data in 2024. TCBP also highlighted its focus on strategic partnerships and platform expansion into anti-fungal and anti-bacterial programs.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:46 pm

IPX

IperionX is advancing towards commercial-scale titanium production with significant progress at its Virginia Titanium Manufacturing Campus. The company has received the first $2.4M from a $12.7M Department of Defense grant for the Phase I ramp-up. The HAMR titanium furnace, a key asset, has passed factory tests and is expected to be installed in Q2 2024, with titanium production starting mid-year. This initiative aims to revitalize the U.S. titanium supply chain, offering high-performance, low-cost titanium products with lower environmental impacts.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:44 pm

EMN

Eastman has entered into a long-term agreement with Nord Pal Plast, part of the Dentis Group, to supply 30,000 metric tons of product per year. This deal signifies a significant commitment between Eastman and Nord Pal Plast and may influence Eastman's production volume and revenue.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:40 pm

AAPL

GOOG

META

Apple Inc. has launched Keyframer, a generative AI tool that animates static images using text prompts. This innovation, part of Apple's expanding AI portfolio, leverages large language models to generate animations from SVG images. Keyframer's development was informed by professional animators and allows for iterative design refinement. This move is in line with Apple's recent AI advancements, including an AI image editing tool and the acquisition of the iWork.ai domain, indicating a strategic push into AI to compete with rivals like Google and Meta Platforms.

Portfolio Pulse from Rounak Jain

February 14, 2024 | 1:39 pm

OPTT

Ocean Power Technologies (OPTT) has been awarded funding by the Naval Postgraduate School for a year-long deployment of its PowerBuoy technology in Monterey Bay. This initiative aims to demonstrate the capabilities and reliability of the PowerBuoy system in a real-world setting.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:19 pm

OTLK

Outlook Therapeutics announced the formal review process for ONS-5010 by the EMA's Committee for Medicinal Products for Human Use, with a decision expected in H1 2024. The company is also exploring an expanded relationship with Cencora, has begun NORSE EIGHT with the first subject dosed, and plans to resubmit the ONS-5010 BLA by the end of CY2024.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:17 pm

GSK

GSK has exercised its option to license Elsie Biotechnologies' discovery platform for finding and developing novel oligonucleotides. This strategic move aims to enhance GSK's capabilities in discovering and developing new therapeutic oligonucleotides, which are short DNA or RNA molecules that can regulate gene expression.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:15 pm